MeSH Browser

MeSH Heading: Maprotiline
Tree Number(s): D02.455.426.559.847.117.600; D04.615.125.600
Unique ID: D008376
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D008376
Scope Note: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Entry Term(s): Ba-34,276; Deprilept; Dibencycladine; Ludiomil; Maprolu; Maprotilin; Maprotilin Holsten; Maprotilin-TEVA; Maprotilin-neuraxpharm; Maprotilin-ratiopharm; Maprotiline Hydrochloride; Maprotiline Mesylate; Mirpan; N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine; Novo-Maprotiline; Psymion; maprotilin von ct
Pharm Action: Antidepressive Agents, Second-Generation
Adrenergic Uptake Inhibitors
Registry Numbers: 2U1W68TROF; 0; 7C8J54PVFI; 22P65W41V0
Related Numbers: 10262-69-8; 10347-81-6; 22P65W41V0; 58902-67-3; 7C8J54PVFI
CAS Type 1 Name: 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-
Previous Indexing: Anthracenes (1972-1974); Propylamines (1972-1974)
Public MeSH Note: 91; was see under ANTHRACENES 1975-90
History Note: 91(75); was see under ANTHRACENES 1975-90
Date Established: 1991/01/01
Date of Entry: 1974/11/19
Revision Date: 2023/06/07

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0013021
Registry Numbers: 2U1W68TROF
Related Numbers: 10262-69-8; 10347-81-6; 22P65W41V0; 58902-67-3; 7C8J54PVFI
Scope Note: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Terms: Maprotiline Preferred Term
Term UI T024911
Date01/01/1999
LexicalTag NON
ThesaurusID; Dibencycladine
Term UI T024910
Date07/30/1980
LexicalTag NON
ThesaurusID UNK (19XX); N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine
Term UI T024912
Date09/09/1993
LexicalTag NON
ThesaurusID; Maprotilin
Term UI T024913
Date11/11/1974
LexicalTag NON
ThesaurusID UNK (19XX)

Maprotiline MeSH Descriptor Data 2025